Chapter 6 Chapter 6
Prospective Analysis: Forecasting
Discussion Questions
1. Merck is one of the largest pharmaceutical firms in the world, and over an extended period of time in
the recent past, it consistently earned higher ROEs than the pharmaceutical industry as a whole. As a
pharmaceutical analyst, what factors would you consider to be important in making projections of future
ROEs for Merck? In particular, what factors would lead you to expect Merck to continue to be a superior
performer in its industry, and what factors would lead you to expect Merck’s future performance to revert
to that of the industry as a whole?
Factors contributing to Merck continuing to be a high ROE performer:
• Barriers to competition. Merck can enjoy superior ROEs for long period of time if it builds high
Factors causing Merck to revert to the industry mean:
• The economics of competition. Abnormally high profit attracts competition. Increased
2. John Right, an analyst with Stock Pickers Inc., claims: “It is not worth my time to develop detailed
forecasts of sales growth, profit margins, et cetera, to make earnings projections. I can be almost as
accurate, at virtually no cost, using the random walk model to forecast earnings.” What is the random
walk model? Do you agree or disagree with John Right’s forecast strategy? Why or why not?
We don’t agree with John. According to the random walk model, the forecast for year t + 1 is
simply the amount observed for year t. The random walk model only describes the average firm’s
behavior. Random walk model may not be applicable to those firms that erect barriers to